Search Within

Stephen D Nimer

Formats
  1. Journal Article (181)
  2. Meeting Abstract (162)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (347)
  2. Hematologic Malignancies, Division of (347)
  3. Center for Hematologic Malignancies (121)
  4. Adult Leukemia (57)
  5. GSK Faculty (56)
  6. Survivorship Research (50)

More Groups

People
  1. Craig Moskowitz (46)
  2. Andrew Zelenetz (40)
  3. Tarun Kewalramani (40)
  4. Raymond Comenzo (36)
  5. Hani Hassoun (31)
  6. Virginia Klimek (30)

More People

Years
  1. 2017 (1)
  2. 2014 (3)
  3. 2013 (8)
  4. 2012 (19)
  5. 2011 (24)
  6. 2010 (17)

More Years

Publications
  1. Blood (175)
  2. Cancer Research (12)
  3. Oncogene (9)
  4. British Journal of Haematology (8)
  5. Leukemia Research (8)
  6. Bone Marrow Transplantation (7)

More Publications

Publishers
  1. American Society of Hematology (176)
  2. Nature Publishing Group (29)
  3. American Association for Cancer Research (19)
  4. Elsevier Inc. (12)
  5. Cell Press (11)
  6. John Wiley & Sons (9)

More Publishers

Results (347)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Myelodysplastic syndromes: Clinical Practice Guidelines in Oncology
    Journal Article

    Greenberg, P. L.; Baer, M. R.; Bennett, J. M.; Bloomfield, C. D.; De Castro, C. M.; Deeg, H. J.; Devetten, M. P.; Emanuel, P. D.; Erba, H. P.; Estey, E.; more...
    Journal of the National Comprehensive Cancer Network (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save
  • High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up
    Journal Article

    Abrey, L. E.; Childs, B. H.; Paleologos, N.; Kaminer, L.; Rosenfeld, S.; Salzman, D.; Finlay, J. L.; Gardner, S.; Peterson, K.; Hu, W.; more...
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Host acid sphingomyelinase regulates microvascular function not tumor immunity
    Meeting Abstract

    Garcia-Barros, M.; Lacorazza, H. D.; Petrie, H.; Haimovitz-Friedman, A.; Cordon-Cardo, C.; Nimer, S.; Fuks, Z.; Kolesnick, R. N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Identification of a MEF gene mutation in a familial hemophagocytic lymphohistiocytosis patient that decreases MEF transcriptional activity
    Meeting Abstract

    Lacorazza, H. D.; LoPiccolo, S.; Rubenstein, E.; Liu, Y.; Nunes, J.; Hasle, H.; Fadeel, B.; Ericson, K.; Henter, J. I.; Nimer, S. D.
    Blood (2005)

    Fulltext@MSK | Save
  • Id1 regulates the choice of hematopoietic stem cells to self-renew or commit to differentiation
    Meeting Abstract

    Jankovic, V.; Ciarrocchi, A.; Boccuni, P.; Benezra, R.; Nimer, S. D.
    Blood (2005)

    Fulltext@MSK | Save
  • Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat
    Meeting Abstract

    Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Plasma cell gene-expression profiles in patients with systemic AL amyloidosis: Responses to melphalan and stem cell transplant are associated with differential expression of genes involved in translation, protein degradation and detoxification
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Wang, L. M.; Nimer, S. D.; Olshen, A. B.
    Blood (2005)

    Fulltext@MSK | Save